These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12162678)

  • 41. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions.
    Nariţa D; Raica M; Anghel A; Suciu C; Cîmpean A
    Rom J Morphol Embryol; 2005; 46(1):41-5. PubMed ID: 16286983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
    Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
    Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
    Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
    Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of complexed PSA for the early detection of prostate cancer.
    Fischer K; Loertzer H; Fornara P
    Anticancer Res; 2005; 25(3A):1591-6. PubMed ID: 16033065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of human prostatic-specific antigen (hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA.
    Pérez L; Zulueta O; Melchor A; Hernández L; López R; Cazanave J; Béquer D
    Hybridoma (Larchmt); 2011 Jun; 30(3):247-51. PubMed ID: 21707359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
    Bjartell A; Johansson R; Björk T; Gadaleanu V; Lundwall A; Lilja H; Kjeldsen L; Udby L
    Prostate; 2006 May; 66(6):591-603. PubMed ID: 16388501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
    Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors.
    Papotti M; Paties C; Peveri V; Moscuzza L; Bussolati G
    Basic Appl Histochem; 1989; 33(1):25-9. PubMed ID: 2471501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
    Perner S; Hofer MD; Kim R; Shah RB; Li H; Möller P; Hautmann RE; Gschwend JE; Kuefer R; Rubin MA
    Hum Pathol; 2007 May; 38(5):696-701. PubMed ID: 17320151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate.
    Sandblom G; Ladjevardi S; Garmo H; Varenhorst E
    Cancer; 2008 Feb; 112(4):813-9. PubMed ID: 18098207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
    Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
    Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
    Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer.
    Zambon CF; Basso D; Prayer-Galetti T; Navaglia F; Fasolo M; Fogar P; Greco E; Pagano F; Plebani M
    Clin Biochem; 2006 Apr; 39(4):333-8. PubMed ID: 16516186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
    Han KR; Seligson DB; Liu X; Horvath S; Shintaku PI; Thomas GV; Said JW; Reiter RE
    J Urol; 2004 Mar; 171(3):1117-21. PubMed ID: 14767283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.